CYTOGRAFT TISSUE ENGINEERING INC has a total of 15 patent applications. Its first patent ever was published in 2000. It filed its patents most often in EPO (European Patent Office), China and Republic of Korea. Its main competitors in its focus markets medical technology, biotechnology and pharmaceuticals are VERIGEN AG, BIOTISSUE TECHNOLOGIES AG and ISOTIS NV.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 6 | |
#2 | China | 2 | |
#3 | Republic of Korea | 2 | |
#4 | United States | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 | |
#6 | Australia | 1 |
# | Industry | |
---|---|---|
#1 | Medical technology | |
#2 | Biotechnology | |
#3 | Pharmaceuticals | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Implantable devices | |
#4 | Object sterilising | |
#5 | Diagnosis and surgery | |
#6 | Unspecified technologies | |
#7 | Therapeutic chemical compounds | |
#8 | Microbiology |
# | Name | Total Patents |
---|---|---|
#1 | L Heureux Nicolas | 14 |
#2 | Mcallister Todd N | 11 |
#3 | Dusserre Nathalie | 5 |
#4 | Mcallister Todd | 4 |
#5 | Garrido Sergio A | 3 |
#6 | Heureux Nicolas L | 1 |
Publication | Filing date | Title |
---|---|---|
WO2013142879A1 | Tissue-engineered heart valve for transcatheter repair | |
CN103534346A | Cell-synthesized particles | |
EP2408380A1 | Guided percutaneous bypass | |
EP2299934A1 | Arterial implants | |
EP2097513A2 | Preparation and use of cell-synthesized threads |